Who is sponsoring NCT01631032?

NCT01631032 is sponsored by Chang Gung Memorial Hospital.

What condition does NCT01631032 study?

NCT01631032 studies Allergic Rhinitis.

What drugs are being tested in NCT01631032?

Interventions: Qi-tonifying Chinese herbal products.

What is the status of NCT01631032?

NCT01631032 is currently COMPLETED.

Last reviewed 2015-08-05 · How we verify

Phase 3 Study of Qi-tonifying Chinese Herbal Products for Treatment of Allergic Rhinitis

NCT01631032 Phase 3 COMPLETED

Allergic rhinitis is a common but complicated immunologic disorder disease and multiple western medicine has been used for symptom control. Chinese herbal medicine, one of the most commonly used complementary and alternative medicine in Taiwan, has also be used for allergic rhinitis control. This study is designed to explore the efficacy and possible underlying immune-modulation effect of the BZYQT, which is one of the most famous Chinese herbal medicine used for allergic rhinitis in daily practice.

Details

Lead sponsor	Chang Gung Memorial Hospital
Phase	Phase 3
Status	COMPLETED
Enrolment	112
Start date	2012-07
Completion	2013-12

Conditions

Allergic Rhinitis

Interventions

Qi-tonifying Chinese herbal products

Primary outcomes

Changes from Baseline in symptom severity at 3 months — Assessment of symptom severity on starting day (day 0), once a month during treatment course (day 30 and day 60), and 1 month after completed treatment (day 90)
Okuda scoring system for allergic rhinitis severity, Short-form 36 (SF-36) for life quality, visual analogue scale for fatigue severity

Countries

Taiwan